Facteurs pronostiques et traitement chirurgical des tumeurs « borderline » de l’ovaire

  • P. Morice
  • S. Camatte
  • C. Lhommé
  • P. Pautier
  • P. Duvillard
  • D. Castaigne
Part of the Abord clinique book series (ONCOLPRAT)


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Tropé C, Kaern J (1998) Management of borderline tumors of the ovary: State of the art. Semin Oncol 25: 372–80PubMedGoogle Scholar
  2. 2.
    Morice P, Camatte S, Rey A et al. (2003) Prognostic factors of patients with advanced stage serous borderline tumor of the ovary. Ann Oncol 14: 592–8PubMedGoogle Scholar
  3. 3.
    Kaern J, Tropé C, Abeler V (1993) A retrospective study of 370 borderline tumors of the ovary treated at the Norwegia Radium Hospital from 1970 to 1982. Cancer 71: 1810–20PubMedGoogle Scholar
  4. 4.
    Tamakoshi K, Kikkawa F, Nakashima N et al. (1997) Clinical behaviour of borderline ovarian tumors: A Study of 150 cases. J Surg Oncol 64: 147–52CrossRefPubMedGoogle Scholar
  5. 5.
    Trimble CL, Kosary C, Trimble E (2002) Long-term survival and patterns of care in women with ovarian tumors of low malignant potential. Gynecol Oncol 86: 34–7CrossRefPubMedGoogle Scholar
  6. 6.
    Leake J, Currie J, Rosenshein N et al. (1992) Long-term follow-up of serous ovarian tumors of low malignant potential. Gynecol Oncol 47: 150–8CrossRefPubMedGoogle Scholar
  7. 7.
    Bell DA, Weinstock RA, Scully R (1988) Peritoneal implants of ovarian serous borderline tumors: histologic features and prognosis. Cancer 62: 2212–22PubMedGoogle Scholar
  8. 8.
    Bell D, Scully R (1990) Serous borderline tumors of the peritoneum. Am J Surg Pathol 14: 230–9PubMedGoogle Scholar
  9. 9.
    Kennedy AW, Hart WR (1996) Ovarian papillary serous tumors of low malignant potential (serous borderline tumors). A long term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma. Cancer 78: 278–86CrossRefPubMedGoogle Scholar
  10. 10.
    Manchul LA, Simm J, Levin W et al. (1992) Borderline Epithelial Ovarian Tumours: a review of 81 cases with an assessment of the impact of the treatment. Int J Rad Oncol Biol Phys 22: 867–74Google Scholar
  11. 11.
    Gershenson D, Silva E, Levy L et al. (1998) Ovarian Serous Borderline Tumors with Invasive Peritoneal Implants. Cancer 82: 1096–103CrossRefPubMedGoogle Scholar
  12. 12.
    Gershenson D, Silva EL, Tortolero-Luna G et al. (1998) Serous Borderline Tumors of the Ovary with Non invasive Peritoneal Implants. Cancer 83: 2157–63CrossRefPubMedGoogle Scholar
  13. 13.
    Seidman J, Kurman R (1996) Subclassification of serous borderline tumors of the ovary into begnin and malignant types: a clinicopathologic study of 65 advanced stage cases. Am J Surg Pathol 20: 1331–45PubMedGoogle Scholar
  14. 14.
    Michael H, Sutton G, Roth L (1987) Ovarian carcinoma with extracellular mucin production: reassessment of « pseudomyxoma ovarii et peritonei ». Int J Gynecol Pathol 6: 298–310PubMedGoogle Scholar
  15. 15.
    Elias D, Sabourin JC (1999) Pseudomyxome peritoneale. Revue de la littérature. J Chir 136: 341–7Google Scholar
  16. 16.
    Darai E, Teboul J, Fauconnier A et al. (1998) Management and outcome of borderline ovarian tumors indicentally discovered at or after laparoscopy. Acta Obstet Gynecol Scand 77: 451–7CrossRefPubMedGoogle Scholar
  17. 17.
    Lim-Tan S, Cajigas H, Scully R (1988) Ovarian cystectomy for serous borderline. tumors: a follow-up study of 35 cases. Obstet Gynecol 72: 775–80PubMedGoogle Scholar
  18. 18.
    Morice P, Camatte S, El Hassan J et al. (2001) Clinical outcomes and fertility results after conservative treatment for ovarian borderline tumor. Fertil Steril 75: 92–6CrossRefPubMedGoogle Scholar
  19. 19.
    Prat J, De Nictolis M (2002) Serous borderline tumors of the ovary: a long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion. Am J Surg Pathol 26: 1111–28CrossRefPubMedGoogle Scholar
  20. 20.
    Gershenson DM (2002) Is micropapillary serous carcinoma for real? Cancer 95: 677–80CrossRefPubMedGoogle Scholar
  21. 21.
    Camatte S, Morice P, Atallah D et al. (2002) Lymph node disorders and prognostic value of nodal involvement in patients treated for borderline ovarian tumor: An analysis of a series of 42 lymphadenectomies. J Am. Coll. Surg 195: 332–8CrossRefPubMedGoogle Scholar
  22. 22.
    Leake JF, Ader JS, Woodruff JD et al. (1991) Retroperitoneal lymphatic involvement with epithelial ovarian tumors of low malignant potential. Gynecol Oncol 42: 124–30CrossRefPubMedGoogle Scholar
  23. 23.
    Lin P, Gershenson D, Bevers M et al. (1999) The Current Status Of Surgical Staging of Ovarian Serous Borderline Tumors. Cancer 85: 905–11PubMedGoogle Scholar
  24. 24.
    Yazigi R, Sanddstad J, Munoy AK (1988) Primary staging in ovarian tumors of low malignant potential. Gynecol Oncol 31: 402–8CrossRefPubMedGoogle Scholar
  25. 25.
    Prade M, Spatz A, Bentley R et al. (1995) Borderline and malignant serous tumor arising in pelvic lymph nodes: evidence of origin in benign glandular inclusions. Int J Gynecol Pathol 14: 87–91PubMedGoogle Scholar
  26. 26.
    Tan LK, Flynn SD, Carcangiu ML (1994) Ovarian serous borderline tumors with lymph node involvement: clinicopathologic and DNA content study of seven cases and review of the litterature. Am J Surg Pathol 18: 904–12PubMedGoogle Scholar
  27. 27.
    Houck K, Nikrui N, Duska L et al. (2000) Borderline tumors of the ovary: correlation of frozen and permanent histopathologic diagnosis. Obstet Gynecol 95: 839–43CrossRefPubMedGoogle Scholar
  28. 28.
    Rose P, Rubin R, Nelson B et al. (1994) Accuracy of frozen-section (intraoperative consultation) diagnosis of ovarian tumors. Am J Obstet Gynecol 171: 823–6PubMedGoogle Scholar
  29. 29.
    Yeo E, Yu K, Poddar NC et al. (1998) The accuracy of intraoperative frozen section in the diagnosis of ovarian tumors. J Obstret Gynecol Res 24: 189–95Google Scholar
  30. 30.
    Atallah D, Morice P, Camatte S et al. (2004) Place et résultats de l’examen extemporané dans la stratégie chirurgicale des tumeurs epithéliales malignes et à la limite de la malignité de l’ovaire. Gynecol Obstet Fertil 32: 651–6CrossRefPubMedGoogle Scholar
  31. 31.
    Robinson WR, Curtin JP, Morrow CP (1992) Operative staging and conservative surgery in the management of low malignant potential ovarian tumors. Int J Gynecol Cancer 2: 113–8CrossRefPubMedGoogle Scholar
  32. 32.
    Massad S, Hunter V, Szpak C et al. (1991) Epithelial ovarian tumors of low malignant potential. Obstet Gynecol 78: 1027–32PubMedGoogle Scholar
  33. 33.
    Fauvet R, Boccara J, Dufournet C et al. (2004) Restaging surgery for women with borderline ovarian tumors. Results of a french multicenter study. Cancer 100: 1145–51CrossRefPubMedGoogle Scholar
  34. 34.
    Rao GG, Skinner E, Gerhig PA et al. (2004) Surgical staging of ovarian low malignant potential tumors. Obstet Gynecol 104: 261–6PubMedGoogle Scholar
  35. 35.
    Camatte S, Morice P, Thoury A et al. (2004) Impact of restaging surgery in patients with macroscopic “ stage I ” ovarian borderline tumors: Analysis of a continous series of 101 cases. Eur J Cancer 40: 1842–9CrossRefPubMedGoogle Scholar
  36. 36.
    Winter WE III, Kucera PR, Rodgers W et al. (2002) Surgical staging in patients with ovarian tumors of low malignant potential. Obstet Gynecol 100: 671–6CrossRefPubMedGoogle Scholar
  37. 39.
    Hopkins MP, Morley GW (1989) The second-look operation and surgical reexploration in ovarian tumor of low malignant potential. Obstet Gynecol 74: 375–8PubMedGoogle Scholar
  38. 37.
    Nation JG, Krepart GV (1986) Ovarian carcinoma of low malignant potential: staging and treatment. Am J Obstet Gynecol 154: 290–3PubMedGoogle Scholar
  39. 38.
    Helewa ME, Krepart GV, Lotocki R (1986) Staging laparotomy in early epithelial ovarian carcinoma. Am J Obstet Gynecol 154: 282–6Google Scholar
  40. 40.
    Snider DD, Stuart GC, Nation JG et al. (1991) Evaluation of surgical staging in stage I low malignant potential ovarian tumors. Gynecol Oncol 40: 129–32CrossRefPubMedGoogle Scholar
  41. 41.
    Querleu D, Papageorgiou T, Lambaudie E et al. (2003) Laparoscopic restaging of borderline ovarian tumours: results of 30 cases initially presumed as stage IA borderline ovarian tumours. BJOG 110: 201–4PubMedGoogle Scholar
  42. 42.
    Land R, Perrin L, Nicklin J (2003) Evaluation of restaging in clinical stage IA low malignant potential ovarian tumours. Aust N Z J Obstet Gynaecol 42: 379–82Google Scholar
  43. 43.
    Julian C, Woodruff D (1972) The biologic behavior of low-grade papillary serous carcinoma of the ovary. Obstet Gynecol 40: 860–7PubMedGoogle Scholar
  44. 44.
    Hart WR, Norris HJ (1973) Borderline and Malignant Mucinous Tumors of the Ovary. Cancer 31: 1031–45PubMedGoogle Scholar
  45. 45.
    Tazelaar H, Bostwick D, Ballon S et al. (1985) Conservative treatment of borderline ovarian tumors. Obstet Gynecol 66: 417–22PubMedGoogle Scholar
  46. 46.
    Tasker M, Langley FA (1985) The outlook for women with borderline epithelial tumours of the ovary. Br J Obstet Gynaecol 92: 969–73PubMedGoogle Scholar
  47. 47.
    Bostwick D, Tazelaar H, Ballon S et al. (1986) Ovarian Epithelial Tumors of Borderline Malignancy. A clinical and pathologic Study of 109 cases. Cancer 58: 2052–65PubMedGoogle Scholar
  48. 48.
    Rice L, Berkowitz R, Mark S et al. (1990) Epithelial ovarian tumors of borderline malignancy. Gynecol Oncol 39: 195–8CrossRefPubMedGoogle Scholar
  49. 49.
    Piura B, Dganis R, Blicksteins I et al. (1992) Epithelial ovarian tumors of borderline malignancy: a study of 50 cases. Int J Gynecol Cancer 2: 189–97CrossRefPubMedGoogle Scholar
  50. 50.
    Barnhill D, Kurman R, Brady M et al. (1995) Preliminary analysis of the behavior of stage I ovarian serous tumors of low malignant potential: A Gynecoloic Oncology Group study. J Clin Oncol 13: 2752–6PubMedGoogle Scholar
  51. 51.
    Gotlieb W, Flikker S, Davidson B et al. (1998) Borderline tumors of the ovary: Fertiliy treatment, conservative management, and pregnancy outcome. Cancer 82: 141–6CrossRefPubMedGoogle Scholar
  52. 52.
    Morris RT, Gershenson DM, Silva EG et al. (2000) Outcome and reproductive function after conservative surgery for borderline ovarian tumors. Obstet Gynecol 95: 541–7CrossRefPubMedGoogle Scholar
  53. 53.
    Camatte S, Rouzier R, Boccara-Dekeyser J et al. (2002) Pronostic et fertilité après traitement conservateur d’une tumeur ovarienne à la limite de la malignité: revue d’une série continue de 68 cas. Gynecol Obstet Fertil 30: 583–91CrossRefPubMedGoogle Scholar
  54. 54.
    Zanetta G, Rota S, Chiari S et al. (2001) Behavior of borderlin tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: A prospective study. J Clin Oncol 19: 2658–64PubMedGoogle Scholar
  55. 55.
    Seracchioli R, Venturoli S, Colombo FM et al. (2001) Fertility and tumor recurrence rate after conservative laparoscopic management of young women with early-stage borderline ovarian tumors. Fertil Steril 76: 999–1004CrossRefPubMedGoogle Scholar
  56. 56.
    Donnez J, Munschke A, Berliere M et al. (2003) Safety of conservative management and fertility outcome in women with borderline tumors of the ovary. Fertil Steril 79: 1216–21PubMedGoogle Scholar
  57. 57.
    Chan JK, Lin YG, Loizzi V et al. (2003) Borderline ovarian tumors in reproductive-age women. Fertility-sparing surgery and outcome. J Reprod Med 48: 756–60PubMedGoogle Scholar
  58. 58.
    Maneo A, Vignali M, Chiari S et al. (2004) Are borderline tumors of the ovary safely treated by laparoscopy? Gynecol Oncol 94: 387–92CrossRefPubMedGoogle Scholar
  59. 59.
    Beiner ME, Gotlieb WH, Davidson B et al. (2001) Infertility treatment after conservative management of borderline ovarian tumors. Cancer 92: 320–5CrossRefPubMedGoogle Scholar
  60. 60.
    Miller DM, Ehlen TG, Saleh EA (1997) Successful term pregnancy following conservative debulking surgery for a stage IIIA serous low-malignant-potential tumor of the ovary: A case report. Gynecol Oncol 66: 535–8PubMedGoogle Scholar
  61. 61.
    Camatte S, Morice P, Pautier P et al. (2002) Fertility results after conservative treatment of advanced stage serous borderline tumors of the ovary. BJOG 109: 376–80PubMedGoogle Scholar
  62. 62.
    Nijman HW, Burger CW, Baak JP et al. (1992) Borderline malignancy of the ovary and controlled hyperstimulation, a report of 2 cases. Eur J Cancer 12: 1971–3Google Scholar
  63. 63.
    Mantzavinos T, Kanakas N, Genatas C et al. (1994) Five years’ follow-up in two patients with borderline tumours of the ovary hyperstimulated by gonadotrophin therapy for in-vitro fertilization. Human Reprod 9: 2032–3Google Scholar
  64. 64.
    Hershkovitz R, Lunenfeld E, Piura B et al. (1998) Ovulation induction in three infertile patients with ovarian borderline tumor. Isr J Obstet Gynecol 9: 271Google Scholar
  65. 65.
    Hoffman JS, Laird L, Benadiva C et al. (1999) In vitro fertilization following conservative management of stage 3 serous borderline tumor of the ovary. Gynecol Oncol 74: 515–8CrossRefPubMedGoogle Scholar
  66. 66.
    Madelenat P, Meneux E, Fernandez H et al. (1999) Place de l’assistance à la procréation après traitement conservateur d’une tumeur ovarienne: enquête multicentrique française. 10e Congrès de la Société française d’oncologie gynécologique. Poitiers. France. 5–6 novembre 1999Google Scholar
  67. 67.
    Attar E, Berckman S, Topuz S et al. (2004) Evolutive peritoneal disease after conservative management and the infertility drugs in a patient with stage IIIC borderline micropapillary serous carcinoma (MPSC) of the ovary: case report. Hum Reprod 19: 1472–5CrossRefPubMedGoogle Scholar
  68. 68.
    Fasouliotis S, Davis O, Schattman G et al. (2004) Safety and efficacy of infertility treatment after conservative management of borderline ovarian tumors: a preliminary report. Fertil Steril 82: 568–72PubMedGoogle Scholar
  69. 69.
    Donnez J, Dolmans MM, Demylle D et al. (2004) Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 364: 1405–10PubMedGoogle Scholar
  70. 70.
    Navot D, Fox JH, Williams M et al. (1991) The concept of uterine preservation with ovarian malignancies. Obstet Gynecol 78: 566–8PubMedGoogle Scholar
  71. 71.
    Gallot D, Pouly JL, Janny L et al. (2000) Successful transfer of frozen-thawed embryos obtained immediatly before radical surgery for a stage IIIa serous borderline ovarian tumour: Case report. Human Reprod 15: 2347–50CrossRefGoogle Scholar
  72. 72.
    Lawal AH, Lynch CB (1996) Borderline ovarian cancer, bilateral surgical castration, chemotherapy and a normal delivery after ovum donation and in vitro fertilisation-embryo transfer. Br J Obstet Gynaecol 103: 931–2PubMedGoogle Scholar
  73. 73.
    Morice P, Thoury A, Sabourin JC et al. (2003) Spontaneous regression of peritoneal implants in borderline ovarian tumor after salpingo-oophorectomy. J Clin Oncol 21: 3536–8CrossRefPubMedGoogle Scholar
  74. 74.
    Candiani M, Vasile C, Sgherzi MR et al. (1999) Borderline ovarian tumors: laparoscopic treatment. Clin Exp Obstet Gynecol 26: 39–43PubMedGoogle Scholar
  75. 75.
    Camatte S, Morice P, Atallah D et al. (2004) Clinical outcomes after laparoscopic treatment of borderline ovarian tumors: results of a series of 34 patients. Ann Oncol 15: 605–9CrossRefPubMedGoogle Scholar
  76. 76.
    Deffieux X, Morice P, Camatte S et al. (2005) Results after laparoscopic treatment of advanced stage borderline ovarian tumor. Gynecol Oncol 97: 84–9CrossRefPubMedGoogle Scholar
  77. 77.
    Hsiu JG, Given FT, Kemp GM (1986) Tumor implantation after diagnostic laparoscopic biopsy of serous ovarian tumors of low malignant potential. Obstet Gynecol 68: 90S–93SPubMedGoogle Scholar
  78. 78.
    Shepherd JH, Carter PG, Lowe DG (1994) Wound recurrence by implantation of a borderline ovarian tumour following laparoscopic removal. BJOG 101: 265–6Google Scholar
  79. 79.
    Morice P, Camatte S, Larregain-Fournier D et al. (2004) Port-site implantation after laparoscopic treatment of borderline ovarian tumors: Clinical aspects and outcomes. Obstet Gynecol 104: 1167–70PubMedGoogle Scholar
  80. 80.
    Zanetta G, Rota S, Lissoni A et al. (2001) Ultrasound, physical examination, and CA 125 measurement for the detection of recurrence after conservative surgery for early borderline ovarian tumors. Gynecol Oncol 81: 63–6CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag France 2006

Authors and Affiliations

  • P. Morice
  • S. Camatte
  • C. Lhommé
  • P. Pautier
  • P. Duvillard
  • D. Castaigne

There are no affiliations available

Personalised recommendations